NCT07147881Not yet recruiting
Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors
Source: ClinicalTrials.gov · Last updated 29 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 22 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Neurolutions, Inc.
- Diseases
- Stroke
- NCT number
- NCT07147881
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Sept 2025 to the primary completion date, 1 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment that would impede utilization of IpsiHand®
Other
- Any contraindications to IpsiHand® device use
- Inability to comprehend English
Who the study is looking for
- Adult age 18-85 years.
- Diagnosis of stroke six or more months prior with upper extremity weakness.
- Has received an IpsiHand® system as a commercial customer for stroke rehabilitation.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.